Similarly, the expression of GPx3 in diabetes and obesity in response to oxidative stress may be dependent on disease progression and chronic adaptations related to PPARγ levels, with higher GPx3 and PPARγ expression observed during disease onset, while levels of both decrease in advanced disease states [52,53]. The gene discussed is GPX3; the disease is Obesity.